Noguchi, R.; Yoshimatsu, Y.; Sin, Y.; Ono, T.; Tsuchiya, R.; Yoshida, H.; Kiyono, T.; Yonemura, Y.; Kondo, T.
Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12, 258. J. Pers. Med. 2023, 13, 1383.
https://doi.org/10.3390/jpm13091383
AMA Style
Noguchi R, Yoshimatsu Y, Sin Y, Ono T, Tsuchiya R, Yoshida H, Kiyono T, Yonemura Y, Kondo T.
Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12, 258. Journal of Personalized Medicine. 2023; 13(9):1383.
https://doi.org/10.3390/jpm13091383
Chicago/Turabian Style
Noguchi, Rei, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya, Hiroshi Yoshida, Tohru Kiyono, Yutaka Yonemura, and Tadashi Kondo.
2023. "Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12, 258" Journal of Personalized Medicine 13, no. 9: 1383.
https://doi.org/10.3390/jpm13091383
APA Style
Noguchi, R., Yoshimatsu, Y., Sin, Y., Ono, T., Tsuchiya, R., Yoshida, H., Kiyono, T., Yonemura, Y., & Kondo, T.
(2023). Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12, 258. Journal of Personalized Medicine, 13(9), 1383.
https://doi.org/10.3390/jpm13091383
